Dissecting the effect of hormone receptor status in patients with HER2-positive early breast cancer: exploratory analysis from the ALTTO (BIG 2-06) randomized clinical trial.
Arlindo R. Ferreira (with Lambertini M). 2019. Breast cancer research and treatment
Neoadjuvant treatment of stage IIB/III triple negative breast cancer with cyclophosphamide, doxorubicin, and Cisplatin (CAP Regimen): A single arm, single center Phase II study (GBECAM 2008/02)
Patterns of Care and Clinical Outcomes of HER2-positive Metastatic Breast Cancer Patients With Newly Diagnosed Stage IV or Recurrent Disease Undergoing First-line Trastuzumab-based Therapy: A Multicenter Retrospective Cohort Study
Modelling cancer outcomes of bone metastatic patients: Combining survival data with N-Telopeptide of type i collagen (NTX) dynamics through joint models 01 Mathematical Sciences 0104 Statistics
Arlindo R. Ferreira (with Loureiro, H.). 2019. BMC Medical Informatics and Decision Making
N-telopeptide of type I collagen long-term dynamics in breast cancer patients with bone metastases: Clinical outcomes and influence of extraskeletal metastases
Patterns of care and clinical outcomes of first-line trastuzumab-based therapy in HER2-positive metastatic breast cancer patients relapsing after (Neo)adjuvant trastuzumab: An Italian multicenter retrospective cohort study